Toxic partnership

NAMA needs developers if it is to work, writes Political Correspondent Conor Ryan.

Toxic partnership
Sat, 15 Aug, 2009 - 01:00

DEVELOPERS were part of the poison, but plans for the National Asset Management Agency (NAMA) mean they will have to stay around to keep the project from collapsing.

They are like leeches used for emergency bloodletting.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Explosion at Donegal service station Planning granted for new petrol station next to site of Creeslough tragedy
Michael Lyster remembered as ‘magic in human form’ at emotional memorial service Michael Lyster remembered as ‘magic in human form’ at emotional memorial service
AI prompt chat bot. Search website to generate data, text or image. Man using computer with artificial intelligence app. Virtual Mental health experts issue warning over AI 'therapy'
CourtsPlace: DublinPlace: EuropePlace: USPerson: Conor RyanPerson: Finance MinisterPerson: Brian LenihanPerson: Liam CarrollPerson: Hugh O’ReganPerson: Paddy KellyPerson: Sean DunnePerson: LenihanPerson: Peter BaconPerson: BaconOrganisation: NAMAOrganisation: National Asset Management AgencyOrganisation: Circuit CourtOrganisation: PricewaterhouseCoopersOrganisation: PwCOrganisation: Anglo Irish BankOrganisation: AngloOrganisation: KaupthingOrganisation: Gulfstream
<p>Sodium valproate, manufactured by Sanofi and sold as Epilim, has been linked to a high risk of serious injury for babies in the womb. File picture</p>

Three more children settle Epilim sodium valproate cases

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited